Prohibits acquisition or disclosure of certain personal health information without consent.
Impact
The implementation of S2107 would significantly bolster the state laws surrounding data privacy, specifically in the realms of healthcare information management. It supports the trend toward greater data protection for individuals, ensuring that their health information cannot be shared or used without their explicit permission. This added layer of protection aligns with existing federal regulations, particularly those set forth by the Health Insurance Portability and Accountability Act (HIPAA), while not diminishing the rights conferred under federal law. The bill allows for individuals to take legal action against violations, with the possibility of receiving damages up to $1,000 per violation, thereby introducing a punitive measure to encourage compliance.
Summary
Senate Bill S2107 aims to strengthen the protections around personal health information by prohibiting healthcare providers, mobile application developers, and third-party developers from acquiring or disclosing an individual's biometric data, health data, or protected health information without obtaining explicit consent. The bill specifies that consent must be informed and given through a clear action or written statement, thereby enhancing individuals' control over their personal data. The bill also mandates that consent must be procured no more than three calendar days prior to any disclosure, establishing a timeframe within which consent must be administered.
Contention
Debates surrounding S2107 are likely to arise over the balance between data protection and the operational efficiencies of healthcare providers and tech companies. While proponents argue that stringent consent requirements will protect consumers, critics may contend that such regulations could hinder healthcare services' ability to operate swiftly and share important health data among providers for diagnostics and treatment. This tension between privacy rights and operational efficiency represents a key point of contention as stakeholders discuss how to implement these new regulations without compromising healthcare delivery.